Golconda M - Search Results

Year	Number of Results
1993	1
1996	1
1997	2
1998	1
1999	1
2001	1
2003	1
2004	1
2005	3
2008	1
2011	1
2024	0

1

Alemtuzumab induction in renal transplantation.

Hanaway MJ, Woodle ES, Mulgaonkar S, Peddi VR, Kaufman DB, First MR, Croy R, Holman J; INTAC Study Group. Hanaway MJ, et al. N Engl J Med. 2011 May 19;364(20):1909-19. doi: 10.1056/NEJMoa1009546. N Engl J Med. 2011. PMID: 21591943 Free article. Clinical Trial.

2

1,25-dihydroxyvitamin D-mediated hypercalcemia in a renal transplant recipient.

Golconda MS, Larson TS, Kolb LG, Kumar R. Golconda MS, et al. Mayo Clin Proc. 1996 Jan;71(1):32-6. doi: 10.4065/71.1.32. Mayo Clin Proc. 1996. PMID: 8538229 Review.

3

Strategies to increase living donor kidney transplants.

Barry JM, Conlin M, Golconda M, Norman D. Barry JM, et al. Among authors: golconda m. Urology. 2005 Nov;66(5 Suppl):43-6. doi: 10.1016/j.urology.2005.06.005. Urology. 2005. PMID: 16194706

4

Mycophenolate mofetil-induced colonic ulceration in renal transplant recipients.

Golconda MS, Valente JF, Bejarano P, Gilinsky N, First MR. Golconda MS, et al. Transplant Proc. 1999 Feb-Mar;31(1-2):272-3. doi: 10.1016/s0041-1345(98)01531-0. Transplant Proc. 1999. PMID: 10083104 No abstract available.

5

Factors associated with improvement in deceased donor renal allograft function in the 1990s.

Keith DS, DeMattos A, Golconda M, Prather J, Cantarovich M, Paraskevas S, Tchervenkov J, Norman DJ. Keith DS, et al. Among authors: golconda m. J Am Soc Nephrol. 2005 May;16(5):1512-21. doi: 10.1681/ASN.2004090813. Epub 2005 Mar 16. J Am Soc Nephrol. 2005. PMID: 15772252

6

Effect of donor recipient age match on survival after first deceased donor renal transplantation.

Keith DS, Demattos A, Golconda M, Prather J, Norman D. Keith DS, et al. Among authors: golconda m. J Am Soc Nephrol. 2004 Apr;15(4):1086-91. doi: 10.1097/01.asn.0000119572.02053.f2. J Am Soc Nephrol. 2004. PMID: 15034113

7

Long-term outcome of kidney transplantation from expanded criteria donors: a single center experience.

Golconda MS, Whiting JF, Smith R, Hayes R, Alexander JW, First MR. Golconda MS, et al. Transplant Proc. 1997 Dec;29(8):3379-81. doi: 10.1016/s0041-1345(97)00948-2. Transplant Proc. 1997. PMID: 9414756 No abstract available.

8

Evidence suggesting that iron and calcium are interrelated in oxidant-induced DNA damage.

Golconda MS, Ueda N, Shah SV. Golconda MS, et al. Kidney Int. 1993 Dec;44(6):1228-34. doi: 10.1038/ki.1993.373. Kidney Int. 1993. PMID: 8301924 Free article.

9

Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.

Gaber AO, Kahan BD, Van Buren C, Schulman SL, Scarola J, Neylan JF; Sirolimus High-Risk Study Group. Gaber AO, et al. Transplantation. 2008 Nov 15;86(9):1187-95. doi: 10.1097/TP.0b013e318187bab0. Transplantation. 2008. PMID: 19005398 Clinical Trial.

10

Economic costs of expanded criteria donors in renal transplantation.

Whiting JF, Golconda M, Smith R, O'Brien S, First MR, Alexander JW. Whiting JF, et al. Among authors: golconda m. Transplantation. 1998 Jan 27;65(2):204-7. doi: 10.1097/00007890-199801270-00010. Transplantation. 1998. PMID: 9458015

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Results by year